Lumida
/ALNT
⌘K
Allient Inc

Allient Inc

ALNT
$93.10USD↑+0.02%+0.02 today

MARKET CAP

1.6B

P/E (TTM)

65.1x

FWD P/E

—

DAY RANGE

$93 – $97

52W RANGE

$42
$119

AI Summary

Stalk
Sell NowMedium

ALNT remains locked in a medium-term downtrend highlighted by a lower-high/lower-low sequence into mid-August. Price is tightly tracking below the declining 9- and 20-day EMAs with no oversold exhaustion emerging. Execution is warranted now on a rejection at the EMAs and prior support-turned-resistance zone for continuation selling.

  • ↑Q2 2026 GAAP EPS $0.80 vs $0.61 est; revenue $153.8 M +10% YoY; net income $10.4 M +85% YoY.
  • ↑Record order backlog drives FY26 EPS upgrade from $2.46 to $2.68.
  • ↓Shares trade at ~$114 vs $66.66 intrinsic value, implying ~25% overvaluation and weak earnings yield.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Allient Inc. (ALNT) is a leading provider of advanced industrial solutions with a strong presence across diverse sectors including aerospace, defense, and data centers. The company is positioned to capitalize on the ongoing demand for high-tech components and systems, driven by the rise of digital transformation and technological advancements in industrial applications. With a robust order backlog and impressive growth metrics, Allient showcases the potential for sustained earnings and revenue growth in a rapidly evolving market.

Bull says

  • ↑Q2 2026 GAAP EPS $0.80 vs $0.61 est; revenue $153.8 M +10% YoY; net income $10.4 M +85% YoY.
  • ↑Record order backlog drives FY26 EPS upgrade from $2.46 to $2.68.
  • ↑Stock triggers “Strong Buy” signal, up 18% to all-time high and 29% in past week.
  • ↑Quarterly dividend of $0.04 underscores strong cash flow generation.
  • ↑High momentum and robust liquidity amid expanding aerospace-defense demand.
  • ↑Record gross margin reflects operational improvements and cost discipline.

Bear says

  • ↓Shares trade at ~$114 vs $66.66 intrinsic value, implying ~25% overvaluation and weak earnings yield.
  • ↓Elevated volatility may spur sharp price swings; negative short interest signals skeptical sentiment.
  • ↓Negative size factor highlights scalability challenges versus larger aerospace peers.
  • ↓CEO sold 70,000 shares, indicating potential insider caution.
  • ↓Interest rate sensitivity may raise borrowing costs, pressuring future profitability.
  • ↓Negative book-to-price ratio suggests challenges in delivering shareholder value.

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 04-09-2026neutral

Transcript signals

Bull points

  • Aerospace and defense sales were a bright spot, increasing 20% due to the timing of certain defense and space programs. We are actively pursuing several promising opportunities in the defense sector, which we anticipate will contribute to growth in the future.
  • Medical market revenue also increased, up 5%, driven by solid demand for surgical instruments and respiratory and breathing equipment.
  • Notably, from the low margin point of 29.9% in the second quarter, we have seen a 160 basis point improvement in gross margin, reflecting a strong sequential recovery.

Bear points

  • $122 million
  • lower industrial automation sales
  • vehicle markets
Read full transcript analysis ›